Jie Fang

Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models

Shivendra V. Singh, Waise Quarni, Maria Goralski et al. · Science Advances · 2021 · 100 citations · Full text

The Role of Inherited TPMT and COMT Genetic Variation in Cisplatin-Induced Ototoxicity in Children With Cancer

Jun J. Yang, Jiahui Lim, Jie Huang et al. · Clinical Pharmacology & Therapeutics · 2013 · 91 citations · Full text

Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8+ T cell activity

Xiaojin Luan, Ting Lei, Jie Fang et al. · Molecular Therapy · 2023 · 49 citations · Full text

KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma

Alexandra D’Oto, Jie Fang, Hongjian Jin et al. · Nature Communications · 2021 · 44 citations · Full text

Development of Second-Generation CDK2 Inhibitors for the Prevention of Cisplatin-Induced Hearing Loss

Robert A. Hazlitt, Tal Teitz, Justine D. Bonga et al. · Journal of Medicinal Chemistry · 2018 · 36 citations · Full text

Cisplatin-induced Hearing Loss, Medicinal Chemistry, Chemoprevention Strategy +14